Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen

被引:20
作者
Singh, Nishant K. [1 ,2 ]
Abualrous, Esam T. [3 ]
Ayres, Cory M. [1 ,2 ]
Noe, Frank [3 ]
Gowthaman, Ragul [4 ]
Pierce, Brian G. [4 ]
Baker, Brian M. [1 ,2 ]
机构
[1] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
[2] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN USA
[3] Free Univ Berlin, Inst Math, Computat Mol Biol Grp, Berlin, Germany
[4] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA
关键词
antigen; binding geometry; MHC; peptide; spherical coordinates; structure; T cell receptor; PEPTIDE COMPLEX; TCR; MHC; RECOGNITION; DOCKING; BIAS;
D O I
10.1002/prot.25829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recognition of antigenic peptides bound to major histocompatibility complex (MHC) proteins by alpha beta T cell receptors (TCRs) is a hallmark of T cell mediated immunity. Recent data suggest that variations in TCR binding geometry may influence T cell signaling, which could help explain outliers in relationships between physical parameters such as TCR-pMHC binding affinity and T cell function. Traditionally, TCR binding geometry has been described with simple descriptors such as the crossing angle, which quantifies what has become known as the TCR's diagonal binding mode. However, these descriptors often fail to reveal distinctions in binding geometry that are apparent through visual inspection. To provide a better framework for relating TCR structure to T cell function, we developed a comprehensive system for quantifying the geometries of how TCRs bind peptide/MHC complexes. We show that our system can discern differences not clearly revealed by more common methods. As an example of its potential to impact biology, we used it to reveal differences in how TCRs bind class I and class II peptide/MHC complexes, which we show allow the TCR to maximize access to and "read out" the peptide antigen. We anticipate our system will be of use in not only exploring these and other details of TCR-peptide/MHC binding interactions, but also addressing questions about how TCR binding geometry relates to T cell function, as well as modeling structural properties of class I and class II TCR-peptide/MHC complexes from sequence information. The system is available at or for download as a script.
引用
收藏
页码:503 / 513
页数:11
相关论文
共 32 条
  • [21] Functional analysis of the antigen binding sites on the MTB/HIV-1 peptide bispecific T-cell receptor complementarity determining region 3α
    Zhou, Chao-Ying
    Wang, Rui-Ning
    He, Wen-Ting
    Luo, Dong-Rong
    Yuan, Si-Rui
    Wen, Qian
    Hu, Sheng-Feng
    Zhou, Xin-Ying
    Ma, Li
    [J]. AIDS, 2023, 37 (01) : 33 - 42
  • [22] IMMUNOCHEMICAL AND MOLECULAR ANALYSIS OF ANTIGEN-BINDING TO LIPID ANCHORED AND SOLUBLE FORMS OF AN MHC INDEPENDENT HUMAN ALPHA/BETA T-CELL RECEPTOR
    BUCHWALDER, A
    KRANGEL, MS
    HAO, P
    DIAMOND, DJ
    [J]. MOLECULAR IMMUNOLOGY, 1994, 31 (11) : 857 - &
  • [23] The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference
    Trolle, Thomas
    McMurtrey, Curtis P.
    Sidney, John
    Bardet, Wilfried
    Osborn, Sean C.
    Kaever, Thomas
    Sette, Alessandro
    Hildebrand, William H.
    Nielsen, Morten
    Peters, Bjoern
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 196 (04) : 1480 - 1487
  • [24] Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation
    Ogonek, Justyna
    Verma, Kriti
    Schultze-Florey, Christian
    Varanasi, Pavankumar
    Luther, Susanne
    Schweier, Patrick
    Kuehnau, Wolfgang
    Goehring, Gudrun
    Dammann, Elke
    Stadler, Michael
    Ganser, Arnold
    Koehl, Ulrike
    Koenecke, Christian
    Weissinger, Eva M.
    Hambach, Lothar
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 199 (02) : 792 - 805
  • [25] Consequences of drug binding to immune receptors: Immune stimulation following pharmacological interaction with immune receptors (T-cell receptor for antigen or human leukocyte antigen) with altered peptide-human leukocyte antigen or peptide
    Pichler, Werner J.
    [J]. DERMATOLOGICA SINICA, 2013, 31 (04) : 181 - 190
  • [26] Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions
    Murray, JS
    Jois, SDS
    Schountz, T
    Ford, SR
    Tawde, MD
    Brown, JC
    Siahaan, TJ
    [J]. JOURNAL OF PEPTIDE RESEARCH, 2002, 59 (03): : 115 - 122
  • [27] Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor(TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells
    Williams, Chad M.
    Schonnesen, Alexandra A.
    Zhang, Shu-Qi
    Ma, Ke-Yue
    He, Chenfeng
    Yamamoto, Tori
    Eckhardt, S. Gail
    Klebanoff, Christopher A.
    Jiang, Ning
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8 : 1 - 14
  • [28] Single-cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus (hCMV)-specific memory T cells reveals effectors and pre-effectors of CD8+- and CD4+-cytotoxic T cells
    Kar, Raunak
    Chattopadhyay, Somdeb
    Sharma, Anjali
    Sharma, Kirti
    Sinha, Shreya
    Arimbasseri, Gopalakrishnan Aneeshkumar
    Patil, Veena S.
    [J]. IMMUNOLOGY, 2024, 172 (03) : 420 - 439
  • [29] High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination
    Wang, M.
    Tang, S. T.
    Lund, O.
    Dziegiel, M. H.
    Buus, S.
    Claesson, M. H.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (03) : 441 - 446
  • [30] ANTIGEN RECOGNITION BY THE T-CELL RECEPTOR IS ENHANCED BY CD8 ALPHA-CHAIN BINDING TO THE ALPHA-3 DOMAIN OF MHC CLASS-I MOLECULES, NOT BY SIGNALING VIA THE CYTOPLASMIC DOMAIN OF CD8-ALPHA
    TANABE, M
    KARAKI, S
    TAKIGUCHI, M
    NAKAUCHI, H
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (02) : 147 - 152